Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


No evidence alleged Bondi gunmen received military training in Philippines
At least 12 killed in Nigeria mining site attack
Russian attack on Ukraine's central Cherkasy injures six, causes blackouts
UN, aid groups warn Gaza operations at risk from Israel impediments
Israel approves natural gas deal with Egypt, Netanyahu says
US approves $11.1 billion largest-ever arms package for Taiwan
Trump adds seven countries to full travel ban list
Indian parliament votes to allow private firms in nuclear power sector
